PROCEPT BioRobotics Corp (PRCT)
About PROCEPT BioRobotics Corp
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $308.1M
- Net income
- -$95.6M
- Total assets
- $508.1M
- Market cap
- $1.6B
- Gross margin
- 63.7%
- Operating margin
- -33.7%
- Net margin
- -31.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $308.1M
- Cost of revenue
- $111.8M
- Gross profit
- $196.2M
- Operating expenses
- $300.1M
- Operating income
- -$103.9M
- Income tax
- $190.0K
- Net income
- -$95.6M
- EPS (basic)
- $-1.72
- EPS (diluted)
- $-1.72
Balance sheet
- Total assets
- $508.1M
- Current assets
- $450.4M
- Total liabilities
- $142.2M
- Current liabilities
- $65.8M
- Shareholders’ equity
- $365.9M
Cash flow
- Operating cash flow
- -$49.0M
- Investing cash flow
- -$9.4M
- Financing cash flow
- $11.2M
- Net cash flow
- -$47.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.6B
- EPS (diluted)
- $-1.72
- Shares outstanding
- 94.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 15, 2021
PROCEPT BioRobotics Corp (PRCT) Stock Price
- Reported a net loss of $95.6M in FY2025.
- Revenue grew 794% from FY2021 to FY2025.
- Gross margin of 63.7%, net margin -31.0%.
- Trading 72% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PROCEPT BioRobotics Corp.
Write a review
News about PROCEPT BioRobotics Corp
News & sentiment via Polygon.io
PROCEPT BioRobotics Corp: frequently asked questions
Is PROCEPT BioRobotics Corp an American company?
PROCEPT BioRobotics Corp is a US-based company headquartered in San Jose, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is PROCEPT BioRobotics Corp headquartered?
PROCEPT BioRobotics Corp is headquartered in San Jose, California, United States.
Is PROCEPT BioRobotics Corp publicly traded?
Yes — PROCEPT BioRobotics Corp is a publicly traded company. Its stock trades under the ticker symbol PRCT on the NASDAQ.
What does PROCEPT BioRobotics Corp do?
PROCEPT BioRobotics Corp is an American Medical Devices company in the Health & Beauty sector.
